Navigation Links
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
Date:11/15/2012

GBI Research found that on average biobetter launches generate more revenues than their corresponding originator therapies. In some scenarios this extended to, the launch of a biobetter therapy substituting the sales from an existing originator product or biobetter therapy.

Scope

- Data and analysis on the impact of biobetter therapeutics on the major top selling biologics erythropoietin's, granulocyte-colony stimulating factors (G-CSF), interferon-?, interferon-beta, insulin and insulin analogs, human growth hormone and monoclonal and mAbs.- Pipeline analysis of biobetter therapies in major protein classes erythropoietin's, G-CSF, interferon-?, interferon-beta, insulin and insulin analogs, mAbs and TNF-?.- Key drivers and restraints that have had a significant impact on the market.- The competitive landscape of the global biobetter therapeutics market, including companies such as Celgene, Amgen, Bristol-Myers Squibb, Amylin and Dainippon Sumitomo Pharma.- Key M&A activities and licensing and co-development agreements that took place from 2010-2012 in the global Biobetters market.

Reasons to buy

- Align your product portfolio to the markets with high growth potential.- Develop business strategies by understanding the trends shaping and driving technological advancements in the field of biobetter therapies.- Identify key molecules in development being used for biobetter therapies. - Reinforce R&D pipelines by identifying common drug class biobetters in the pipeline for top selling protein classes.- Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

Table of Contents

1 Table of Contents1 Table of Contents 61.1 List of Tables 81.2 List of Figures 82 Introduction 93 Global Market Overview 113.1 Biobetter Therapies Already on the Market 113.1.1 Erythropoietins 123.1.2 Granulocyte-colony Stimulating Factors 143.1.3 Interferon-?, Interferon-
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. AspenBio to Present at 2012 Lazard Capital Markets Healthcare Conference
2. Palatin Technologies, Inc. To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
3. Regulus to Present at the Lazard Capital Markets Healthcare Conference
4. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
5. Tengion to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
6. Sangamo BioSciences Announces Presentation At The Lazard Capital Markets Healthcare Conference
7. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
8. Kinase Inhibitors: Global Markets -- Focus on the U.S.
9. MarketsandMarkets: Global Refurbished Medical Equipments Market worth $8.45 Billion by 2017
10. MarketsandMarkets: Global Spine Surgery Devices Market Worth $14.8 Billion by 2017
11. MarketsandMarkets: World Sensors Market in Healthcare Applications is expected to reach $13.11 billion by 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... SEGUNDO, Calif. , July 30, 2014 /PRNewswire/ ... contractor on the Fully Integrated Lifecycle Mission Support ... and Space Administration (NASA). Under the terms of ... Ames Research Center at Moffett Field, Calif. In ... support for bioscience flight development projects on the ...
(Date:7/30/2014)... July 30, 2014. Applied DNA ... that provides DNA-based authentication and security solutions and services, ... of Life Sciences, a newly created position, with a ... will lead APDN’s drive to build its business in ... healthcare customers, provide guidance to APDN’s R&D efforts, and ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Vycom announces ... of products, designed to meet Factory Mutual (FM) 4910 ... materials such as wet benches, process tools, fume hoods, ... safety and damage to semiconductor wafers used in electronic ... a flame-retardant PVC solution with excellent workability and superior ...
(Date:7/30/2014)... , July 30, 2014  Orexigen Therapeutics, Inc. (Nasdaq: ... the Day 180 List of Outstanding Issues (LOI) from ... Human Use (CHMP) for the NB32 Marketing Authorization Application ... is an investigational drug candidate being evaluated for weight ... Day 120 time point were adequately addressed by the ...
Breaking Biology Technology:Wyle Wins NASA's Fully Integrated Lifecycle Mission Support Services Contract 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Vycom Announces Flametec® Thermax PVC (FM4910 Listed) For a Variety of Clean Room Applications with Excellent Workability and Aesthetics 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3
... 2011 Reportlinker.com announces that a ... in its catalogue: ... Immunodiagnostics Markets: US, Europe, Japan Product ... for Instrumentand Reagent Suppliers ...
... 25, 2011 Practice Fusion , the ... working with Microsoft,s DataMarket on the Windows Azure Marketplace ... developers and researchers is part of the Health 2.0 ... Developer Challenge with the support of the Chief Technology ...
... Jan. 25, 2011 Reportlinker.com announces that ... in its catalogue: Future ... of Emerging Reimbursement, Technological and Market Trends ... How will the ...
Cached Biology Technology:Reportlinker Adds The 2011 Clinical Chemistry and Immunodiagnostics Markets: US, Europe, Japan Product Development Opportunities and Business Expansion Strategies for Instrumentand Reagent Suppliers 2Practice Fusion Invites Health Researchers to 'Analyze This!' Contest on Windows Azure 2Practice Fusion Invites Health Researchers to 'Analyze This!' Contest on Windows Azure 3Reportlinker Adds Future US In Vitro Diagnostics Market: Strategic Implications of Emerging Reimbursement, Technological and Market Trends Through 2018 2
(Date:7/30/2014)... infection could be as simple as inserting a medicated, ... of Washington bioengineers have discovered a potentially faster way ... contracting HIV. Their method spins the drug into silk-like ... releasing higher doses of the drug than possible with ... "This could offer women a potentially more effective, discreet ...
(Date:7/30/2014)... climate threaten some of the world,s most rare ... seed collections to save the seeds in banks ... genetic diversity., For decades, these seed collections have ... one-size-fits-all approach for how many seeds to gather, ... of species, pollination mode, growth habitat and population ...
(Date:7/30/2014)... Americans make better decisions about what they eat, the ... significant changes to the Nutrition Facts label found on ... in Chemical & Engineering News (C&EN), the ... the suggested updates and the fight that has ... points out that while the Nutrition Facts label has ...
Breaking Biology News(10 mins):Dissolvable fabric loaded with medicine might offer faster protection against HIV 2Dissolvable fabric loaded with medicine might offer faster protection against HIV 3Saving seeds the right way can save the world's plants 2
... have charted the path of insulin action in cells in ... for understanding what goes wrong in diabetes. The ... from Sydney,s Garvan Institute of Medical Research, is now published ... Cell Metabolism . First discovered in 1921, the insulin ...
... (MAY 20, 2013) University of Minnesota Medical School ... in partnership with the University,s Brain Tumor Program, have ... sheath tumors (MPNST) that allow them to discover new ... The research was published this week in the ...
... A National Science Foundation (NSF) planning grant will help ... a joint program of the University of Illinois at ... "CARD will be devoted to research in drying ... products; forestry and paper products; chemical products; textiles; and ...
Cached Biology News:Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3U of M researchers develop model for better testing, targeting of MPNST 2NSF approves planning grant for Center for Advanced Research in Drying 2
... ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C 14 H 15 ... ,M.W.= 408.63 ,Assay: Greater than ... DMF) ,Biological Activity: Blue color with ... Agrees with theoretical values ,Thin Layer ...
Immunochemistry 1 & 2...
Vertical Rack (five box vapor phase rack), includes 2.0" (5.1cm) boxes...
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
Biology Products: